Centers & Services

Department of General Thoracic Surgery Department

What is General Thoracic Surgery?

We provide surgical treatment for patients with diseases of the lung, mediastinum, chest wall, etc.

Our physicians

Director, Department of General Thoracic Surgery

Shinichi Toyooka, Professor
[Lung cancer, mediastinal tumor, and respiratory diseases]

Staff

Takahiro Oto Professor (Transplantation Center) [Thoracic surgery (lung cancer, mediastinal tumor, pulmonary emphysema) and lung transplantation surgery]
Masaomi Yamane Associate Professor [Thoracic surgery (lung cancer, mediastinal tumor, pulmonary emphysema) and lung transplantation surgery]
Junichi Soh Lecturer [Thoracic malignant tumor surgery (lung cancer, mediastinal tumor, mesothelioma, sarcoma), thoracoscopic surgery]
Seiichiro Sugimoto Assistant Professor [Thoracic surgery (lung cancer, mediastinal tumor, pulmonary emphysema) and lung transplantation surgery]
Hiromasa Yamamoto Assistant Professor [Thoracic malignant tumor surgery (lung cancer, mediastinal tumor, mesothelioma, sarcoma), thoracoscopic surgery]
Shinji Otani Assistant Professor(Transplantation Center) [Thoracic surgery (lung cancer, mediastinal tumor, pulmonary emphysema) and lung transplantation surgery]
Kazuhiko Shien Assistant Professor [Thoracic malignant tumor surgery (lung cancer, mediastinal tumor, mesothelioma, sarcoma), thoracoscopic surgery]
Takeshi Kurosaki (Transplantation Center) [Thoracic surgery (lung cancer, mediastinal tumor, pulmonary emphysema) and lung transplantation surgery]

*Specialty shown in [ ]

Outpatient physicians

Monday Tuseday Wednesday Thursday Friday
Outpatient physicians   Professor (Director) Professor Lecturer Assistant Professor   Professor (lung transplantation) Lecturer Assistant Professor Professor (Director) Lecturer Assistant Professor

Treatment system

Our staff members are Shinichi Toyooka, Takahiro Oto, Masaomi Yamane, Junichi Soh, Seiichiro Sugimoto, Hiromasa Yamamoto, Shinji Otani, Kazuhiko Shien, Takeshi Kurosaki.
The outpatient clinic is available on Tuesdays, Thursdays, and Fridays.

Treatment policy

Surgical conference is held every week to provide optimal treatment for each patient who undergoes surgery.
We also hold a conference every two-week with the Department of Respiratory Medicine and the Department of Radiology, and discuss the applicability of surgery, chemotherapy, radiotherapy and radiofrequency ablation, etc., from different points of view.

Specialties

We have performed lung transplantation in a steadily increasing number of cases since the first case in Japan in 1998. The number reached 100 in November 2012. The total number of cases as of the end of 2016 was 164, the largest number of cases in Japan. The outcomes have also been excellent and at the top level world-wide, with the 5-year survival rate over 80%. In addition, for malignant lung tumors, we provide various treatments from extensive operations using techniques developed in lung transplantation to minimally invasive surgical procedures such as complete VATS lobectomy.

Scope of target diseases

The scope of target diseases covers widely various thoracic diseases in general, including diseases to which lung transplantation is applicable, primary lung cancer, pleural mesothelioma, metastatic lung tumor, pneumothorax, mediastinal tumor, chest wall tumor, myasthenia gravis, emphysema, and infectious lung disease to which surgical treatment is applicable. For details of individual diseases, see the website opend by our own department.

Highly advanced/special medical treatments

Techniques covered by health insurance programs

  • Complete VATS for lung cancer (lobectomy, segmentectomy and partial resection)
  • Lung cancer surgery after induction chemoradiotherapy (including complication ablation of great vessels and vertebral bodies, and pulmonary angioplasty and bronchoplasty)
  • Complete VATS for mediastinal tumor
  • Complete VATS extended thymectomy for myasthenia gravis
  • Team medical care for safe respiratory surgery via intensive pre-operative and postoperative management
  • Development of surgical procedures to avoid pneumonectomy (autologous lung transplantation and complicated bronchoplasty)
  • Living-donor lung transplantation and brain-dead donor lung transplantation

  • Postoperative adjunctive chemotherapy for EGFR mutation-positive lung cancer (investigator-initiated trial)
  • Postoperative adjunctive therapy for Stage I to Stage III lung cancer (two trials)
  • Gene therapy for malignant pleural mesothelioma by REIC gene transfer (in preparation)
  • Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.

Techniques performed in translational studies

  • Genetic and molecular analysis and therapeutic applications toward tailor-made therapy for lung cancer
  • Study to overcome resistance to a molecular targeted therapy drug in lung cancer
  • Study of the effects of a novel, molecularly targeted drug in lung cancer and malignant mesothelioma
  • Study of gene therapy for lung cancer by REIC gene transfer
  • Study for the early detection of malignant pleural mesothelioma by blood testing

Our motto

We provide the best medical care to satisfy every patient.